Viridian Therapeutics
VRDN
VRDN
11 hedge funds and large institutions have $406K invested in Viridian Therapeutics in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
HighTower Advisors
Chicago,
Illinois
|
$210K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$29K |
| 3 |
3
Goldman Sachs
New York
|
$6K |
| 4 |
ICAS
4
Investors Capital Advisory Services
Lynnfield,
Massachusetts
|
$20K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
HighTower Advisors
Chicago,
Illinois
| $210K | 411,614 | +69,984 | +20% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $69K | 136,111 | -36,650 | -21% |
|
|
PCM
3
Perkins Capital Management
Wayzata,
Minnesota
| $44K | 86,050 | -17,000 | -16% |
|
|
4
Citadel Advisors
Miami,
Florida
| $29K | 57,106 | +29,057 | +104% |
|
|
ICAS
5
Investors Capital Advisory Services
Lynnfield,
Massachusetts
| $20K | 39,250 | +1,000 | +3% |
|
|
VKH
6
Virtu KCG Holdings
New York
| $12K | 22,825 | -9,414 | -29% |
|
7
UBS Group
Zurich,
Switzerland
| $9K | 17,735 | -2,409 | -12% |
|
8
Creative Planning
Overland Park,
Kansas
| $7K | 13,165 | – | – |
|
|
9
Goldman Sachs
New York
| $6K | 12,076 | +12,076 | New |
|
10
Nomura Holdings
Tokyo,
Japan
| – | – | -16,100 | Closed |
|
|
TDC
11
Thompson Davis & Co
Richmond,
Virginia
| – | – | -10,500 | Closed |
|
12
Citigroup
New York
| – | – | -501 | Closed |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $0 | 15 | -13 | -46% |
|
14
Morgan Stanley
New York
| $0 | 19 | +1 | +6% |
|